Verrica Pharmaceuticals Inc
F:1NE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Verrica Pharmaceuticals Inc
F:1NE
|
US |
|
M
|
Muangthai Capital PCL
SET:MTC
|
TH |
|
F
|
Fifth Third Bancorp
XMUN:FFH
|
US |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
SWB:BBVA
|
ES |
|
Entra ASA
F:2EN
|
NO |
|
P
|
Plug Power Inc
F:PLUN
|
US |
|
M
|
Marsh & McLennan Companies Inc
F:MSN
|
US |
|
Norsk Hydro ASA
F:NOHA
|
NO |
|
S
|
Smurfit Kappa Group PLC
XMUN:SK3
|
IE |
|
C
|
CH Robinson Worldwide Inc
F:CH1A
|
US |
Shareholder Yield
Current shareholder yield for
1NE is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
1NE Price
Verrica Pharmaceuticals Inc
| Average Annual Return | 25.04% |
| Standard Deviation of Annual Returns | 118.19% |
| Max Drawdown | -97% |
| Market Capitalization | 141.6m EUR |
| Shares Outstanding | 42 420 000 |
| Percentage of Shares Shorted |
N/A
|
1NE Return Decomposition
Main factors of price return
Stock Splits
1NE's latest stock split occurred on Jul 25, 2025
The company executed a 1-for-10 stock split, meaning that for every 10 shares held, investors received 1 new share.
Before the split, 1NE traded at 5.84 per share. Afterward, the share price was about 5.84.
The adjusted shares began trading on Jul 25, 2025. This was the only stock split in 1NE's history.